Clinical trial
Non-inferiority Randomized Controlled Trial of Cognitive Fusion Targeted Biopsy Versus Software-based Fusion Targeted Biopsy
NCT04271527 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-inferiority Randomized Controlled Trial of Cognitive Fusion Targeted Biopsy Versus Software-based Fusion Targeted Biopsy
- Lead sponsor
- Shanghai East Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 20, 2024
- Completion date
- May 14, 2025
- Enrollment
- 626 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer